Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Bought by State Street Corp

State Street Corp lifted its holdings in Rockwell Medical, Inc. (NASDAQ:RMTI) by 21.5% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 95,004 shares of the company’s stock after purchasing an additional 16,800 shares during the quarter. State Street Corp’s holdings in Rockwell Medical were worth $377,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of RMTI. Concurrent Investment Advisors LLC bought a new position in Rockwell Medical in the 3rd quarter valued at about $40,000. Verus Capital Partners LLC acquired a new stake in shares of Rockwell Medical in the 3rd quarter worth approximately $51,000. Beacon Financial Advisory LLC bought a new position in shares of Rockwell Medical in the third quarter valued at approximately $98,000. Renaissance Technologies LLC increased its stake in shares of Rockwell Medical by 877.1% during the second quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after acquiring an additional 92,189 shares during the period. Finally, HighTower Advisors LLC raised its holdings in Rockwell Medical by 75.6% during the third quarter. HighTower Advisors LLC now owns 57,413 shares of the company’s stock worth $228,000 after purchasing an additional 24,715 shares in the last quarter. 23.31% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on RMTI shares. HC Wainwright reaffirmed a “buy” rating and set a $7.00 price target on shares of Rockwell Medical in a research note on Monday, December 23rd. Rodman & Renshaw initiated coverage on Rockwell Medical in a research note on Thursday, November 14th. They set a “buy” rating and a $5.00 target price for the company. StockNews.com lowered Rockwell Medical from a “buy” rating to a “hold” rating in a report on Friday, December 20th. Finally, RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a report on Thursday, November 14th.

Rockwell Medical Trading Up 5.0 %

NASDAQ:RMTI opened at $2.33 on Friday. The stock has a fifty day simple moving average of $2.61 and a 200 day simple moving average of $2.71. The company has a quick ratio of 2.00, a current ratio of 2.41 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $75.30 million, a price-to-earnings ratio of -46.60 and a beta of 1.38. Rockwell Medical, Inc. has a 1-year low of $1.16 and a 1-year high of $5.15.

Rockwell Medical Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.